Tag: chimerix

April 14, 2019

5 Top Weekly NASDAQ Biotech Stocks: PhaseBio Gets Breakthrough Therapy Designation

Vital Therapies, Precipio, Chimerix, ContraFect and PhaseBio Pharmaceuticals were last week's top gainers.
June 7, 2018

Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox

Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that the U.S. Food and Drug...